Biotech Growth Investors & VC Firms
708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Spruce Capital Partners
South San FranciscoSeries A–Growth
3 people
NXT2B
UppsalaSeed–Growth
4 people
Companion Fund
New YorkPre-Seed–Growth
Xerys
ParisSeed–Late Stage$16M – $97M
1 person
YF Capital
ShanghaiSeries A–Late Stage
4 people
Patient Square Capital
Menlo ParkGrowth
PrairieGold Venture Partners
Sioux FallsGrowth$250K – $2M
3 people
Syngenta Group Ventures
DurhamSeed–Growth$500K – $5M
6 people
Zen11 Holding
GrazSeries A–Growth
EDB Investments
SingaporeSeed–Late Stage
11 people
NGN Capital
New YorkSeries A–Late Stage
5 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
Brama One Ventures
SurabayaSeed–Growth
2 people
Horizon Technology Finance
FarmingtonGrowth–Late Stage
2 people
Sangel Capital
ShenzhenSeed–Late Stage
2 people
Elevat3 Capital
VallettaSeed–Growth$5M – $20M
1 person
iBionext
ParisPre-Seed–Growth
4 people
Waterpoint Lane
MiamiSeed–Growth
3 people
London & Scottish Investment Partners
EdinburghGrowth$130K – $320K
2 people
Abbhi Capital
MiamiSeed–Late Stage
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
3 people
TAYA Venture Capital
New Taipei CityPre-Seed–Growth
5 people
Arkin Digital Health
Seed–Late Stage
1 person
Northspring Capital Partners
CambridgeGrowth
1 person
Related lists
Growth Investors & VC Firms (4263)Biotech Investors & VC Firms (2475)Growth Investors & VC Firms in North America (2121)Biotech Seed Investors & VC Firms (2020)Growth Investors & VC Firms in United States (1837)Growth Investors & VC Firms in Europe (1633)Biotech Series A Investors & VC Firms (1626)Biotech Investors & VC Firms in North America (1594)Biotech Investors & VC Firms in United States (1445)Growth Investors & VC Firms in Global (1377)
Data sourced from public filings and firms' own websites — see our methodology.





































